Cytotoxic drugs for gastric and colorectal cancer.
暂无分享,去创建一个
[1] S M Mason,et al. Automated system for screening hearing using the auditory brainstem response. , 1988, British journal of audiology.
[2] P. Wolff. THE DEVELOPMENT OF ATTENTION IN YOUNG INFANTS , 1965, Annals of the New York Academy of Sciences.
[3] W. Shakespeare,et al. As you like It , 1983, Gastroenterology.
[4] A. Markides. Age at fitting of hearing aids and speech intelligibility. , 1986, British journal of audiology.
[5] P. Boyle,et al. Advanced gastric cancer: Experience in Scotland using 5‐fluorouracil, adriamycin and mitomycin‐C , 1984, The British journal of surgery.
[6] R. L. Fantz,et al. Pattern vision in young infants , 1958 .
[7] V. Vaitkevicius,et al. Cisplatin.An active drug in the treatment of disseminated gastric cancer , 1984, Cancer.
[8] A. Neetens,et al. Visual evoked potentials. , 1982, Bulletin de la Societe belge d'ophtalmologie.
[9] M. O’connell. A phase III trial of 5‐fluorouracil and leucovorin in the treatment of advanced colorectal cancer. A mayo clinic/north central cancer treatment group study , 1989, Cancer.
[10] T. Fleming,et al. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin. , 1985, JAMA.
[11] J. Bhattacharya,et al. Long term follow up of newborns tested with the auditory response cradle. , 1984, Archives of disease in childhood.
[12] D. Curnock,et al. Auditory screening of special care neonates using the auditory response cradle. , 1984, Archives of disease in childhood.
[13] F. Cavalli,et al. A phase II study of cisplatin in advanced gastric cancer. , 1983, European journal of cancer & clinical oncology.
[14] C. Erlichman,et al. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] J. Connell,et al. Click evoked otoacoustic emissions compared with brain stem electric response. , 1989, Archives of disease in childhood.
[16] R. Coombes,et al. PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONIST , 1987, The Lancet.
[17] E. Javel,et al. Prognostic validity of auditory brainstem evoked response screening in newborn infants. , 1985, American journal of otolaryngology.
[18] P. Woolley,et al. 5‐fluorouracil, adriamycin, and mitomycin‐c (fam) combination chemotherapy in the treatment of advanced gastric cancer , 1979, Cancer.